keyword
https://read.qxmd.com/read/37269359/dexamethasone-dose-dependently-prevents-taxane-associated-acute-pain-syndrome-in-breast-cancer-treatment
#21
JOURNAL ARTICLE
Yoshitaka Saito, Yoh Takekuma, Takashi Takeshita, Tomohiro Oshino, Mitsuru Sugawara
PURPOSE: Taxane-associated acute pain syndrome (T-APS) is one of the most bothersome adverse effects caused by taxanes. We have previously reported the attenuating effect of dexamethasone (DEX) on T-APS and its risk factors under DEX prophylaxis. However, the appropriate DEX dosage administration remains unclear. Therefore, this study aimed to investigate whether DEX dose-dependently prevents T-APS in breast cancer patients. METHODS: We retrospectively evaluated patients with breast cancer who received docetaxel (75 mg/m2 )-containing chemotherapy without pegfilgrastim and regular non-steroidal anti-inflammatory drugs...
June 3, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/37223407/a-self-healable-metallohydrogel-for-drug-encapsulations-and-drug-release
#22
JOURNAL ARTICLE
Mita Dutta, Shreya Banerjee, Mahitosh Mandal, Manish Bhattacharjee
A self-healable metallohydrogel (MOG) of Mn(ii) has been prepared using a low molecular weight gelator, Na2 HL {H3 L = l-(3,5-di- tert -butyl-2-hydroxy-benzyl)amino aspartic acid}. The MOG has been characterized by MALDI TOF mass spectrometry, rheological studies, IR spectroscopy, and microscopic techniques. Non-steroidal anti-inflammatory drug (NSAID), indomethacin (IND) and anti-cancer drug gemcitabine (GEM) were encapsulated into the metallohydrogel. The GEM-loaded metallogel (MOG_GEM) shows better delivery and more adverse cytotoxicity than the drug against breast cancer cell lines MDA-MB-468 and 4T1...
May 22, 2023: RSC Advances
https://read.qxmd.com/read/37189343/triphenyltin-iv-carboxylates-with-exceptionally-high-cytotoxicity-against-different-breast-cancer-cell-lines
#23
JOURNAL ARTICLE
Ivana Predarska, Mohamad Saoud, Ibrahim Morgan, Peter Lönnecke, Goran N Kaluđerović, Evamarie Hey-Hawkins
Organotin(IV) carboxylates are a class of compounds explored as alternatives to platinum-containing chemotherapeutics due to propitious in vitro and in vivo results, and distinct mechanisms of action. In this study, triphenyltin(IV) derivatives of non-steroidal anti-inflammatory drugs (indomethacin (HIND) and flurbiprofen (HFBP)) are synthesized and characterized, namely [Ph3 Sn(IND)] and [Ph3 Sn(FBP)]. The crystal structure of [Ph3 Sn(IND)] reveals penta-coordination of the central tin atom with almost perfect trigonal bipyramidal geometry with phenyl groups in the equatorial positions and two axially located oxygen atoms belonging to two distinct carboxylato (IND) ligands leading to formation of a coordination polymer with bridging carboxylato ligands...
March 26, 2023: Biomolecules
https://read.qxmd.com/read/37175189/ph-sensitive-gold-nanorods-for-non-steroidal-anti-inflammatory-drugs-nsaids-delivery-and-dna-binding-studies
#24
JOURNAL ARTICLE
Eleni Zygouri, Vlasoula Bekiari, Georgios Malis, Nikos K Karamanos, Christos Koutsakis, George Psomas, Vassilis Tangoulis
A facile experimental protocol for the synthesis of poly(ethylene glycol)-modified (PEGylated) gold nanorods (AuNRs@PEG) is presented as well as an effective drug loading procedure using the non-steroidal anti-inflammatory drug (NSAID) naproxen (NAP). The interaction of AuNRs@PEG and drug-loaded AuNRs (AuNRs@PEG@NAP) with calf-thymus DNA was studied at a diverse temperature revealing different interaction modes; AuNRs@PEG may interact via groove-binding and AuNRs@PEG@NAP may intercalate to DNA-bases. The cleavage activity of the gold nanoparticles for supercoiled circular pBR322 plasmid DNA was studied by gel electrophoresis while their affinity for human and bovine serum albumins was also evaluated...
April 27, 2023: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/37158602/selectively-attacking-tumor-cells-of-ru-ir-arene-complexes-based-on-meclofenamic-acid-via-cyclooxygenase-2-inhibition
#25
JOURNAL ARTICLE
Yuanlei Huang, Mengdi Lv, Binglian Guo, Guojing Hu, Yong Qian, Zhi Su, Xuling Xue, Hong-Ke Liu
Breast cancer (BC) is one of the most common malignant tumors and often accompanied by inflammatory processes. Inflammation is an essential component of the tumor microenvironment, which might influence tumor proliferation and metastasis. Herein, three metal-arene complexes MA-bip-Ru, MA-bpy-Ir, and MA-bpy-Ru were prepared by tethering the non-steroidal anti-inflammatory drug meclofenamic acid (MA). Among them, MA-bip-Ru and MA-bpy-Ir showed lower cytotoxicity towards cancer cells, but MA-bpy-Ru showed significantly high selectivity and cytotoxicity towards MCF-7 cells through the autophagic pathway and exhibited no toxicity against normal HLF cells, showing potential for selective treatment of tumor cells...
May 9, 2023: Dalton Transactions: An International Journal of Inorganic Chemistry
https://read.qxmd.com/read/37101728/prescription-non-steroidal-anti-inflammatory-drugs-nsaids-and-incidence-of-depression-among-older-cancer-survivors-with-osteoarthritis-a-machine-learning-analysis
#26
JOURNAL ARTICLE
Nazneen Fatima Shaikh, Chan Shen, Traci LeMasters, Nilanjana Dwibedi, Amit Ladani, Usha Sambamoorthi
OBJECTIVES: This study examined prescription NSAIDs as one of the leading predictors of incident depression and assessed the direction of the association among older cancer survivors with osteoarthritis. METHODS: This study used a retrospective cohort (N = 14, 992) of older adults with incident cancer (breast, prostate, colorectal cancers, or non-Hodgkin's lymphoma) and osteoarthritis. We used the longitudinal data from the linked Surveillance, Epidemiology, and End Results -Medicare data for the study period from 2006 through 2016, with a 12-month baseline and 12-month follow-up period...
2023: Cancer Informatics
https://read.qxmd.com/read/36978255/cyclooxygenase-2-as-a-therapeutic-target-against-human-breast-cancer-a-comprehensive-review
#27
REVIEW
Ankita Sahu, Khalid Raza, Dibyabhaba Pradhan, Arun Kumar Jain, Saurabh Verma
Cyclooxygenase-2 (COX-2) is a key aspect of the physiology and pathogenesis of various cancer types. Overexpression of this enzyme is responsible for the elevated prostaglandin production and characteristic feature of breast cancer. Inhibition of COX-2 derived prostanoids facilitates anti-inflammatory, analgesic, and antipyretic effects of non-steroid anti-inflammation drugs. The overexpression of COX-2 is associated with inflammation, pain, and fever. The present study provides the updated relevant literature describing the role of well-characterized isoforms of cyclooxygenase with particular emphasis on COX-2, mechanism of action, the effect of the drug, combinatorial drugs, and microarray-based differential expression analysis and network analysis...
March 28, 2023: WIREs Mech Dis
https://read.qxmd.com/read/36765650/use-of-nonsteroidal-anti-inflammatory-drugs-and-risk-of-breast-cancer-evidence-from-a-general-female-population-and-a-mammographic-screening-cohort-in-sweden
#28
JOURNAL ARTICLE
Kejia Hu, Maria Feychting, Donghao Lu, Arvid Sjölander, Kamila Czene, Per Hall, Fang Fang
A link has been proposed between the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of breast cancer. There is, however, insufficient data regarding the subtype and stage of breast cancer, and few studies have assessed the interaction between the use of NSAIDs and breast density or previous breast disorders. There is also a lack of data from population-based studies. We first conducted a nested case-control study within the general female population of Sweden, including 56,480 women with newly diagnosed breast cancer during 2006-2015 and five breast cancer-free women per case as controls, to assess the association of NSAID use with the risk of incident breast cancer, focusing on subtype and stage of breast cancer as well as the interaction between NSAID use and previous breast disorders...
January 23, 2023: Cancers
https://read.qxmd.com/read/36765604/novel-non-cyclooxygenase-inhibitory-derivative-of-sulindac-inhibits-breast-cancer-cell-growth-in-vitro-and-reduces-mammary-tumorigenesis-in-rats
#29
JOURNAL ARTICLE
Heather N Tinsley, Bini Mathew, Xi Chen, Yulia Y Maxuitenko, Nan Li, Whitney M Lowe, Jason D Whitt, Wei Zhang, Bernard D Gary, Adam B Keeton, William E Grizzle, Clinton J Grubbs, Robert C Reynolds, Gary A Piazza
The nonsteroidal anti-inflammatory drug (NSAID) sulindac demonstrates attractive anticancer activity, but the toxicity resulting from cyclooxygenase (COX) inhibition and the suppression of physiologically important prostaglandins precludes its long-term, high dose use in the clinic for cancer prevention or treatment. While inflammation is a known tumorigenic driver, evidence suggests that sulindac's antineoplastic activity is partially or fully independent of its COX inhibitory activity. One COX-independent target proposed for sulindac is cyclic guanosine monophosphate phosphodiesterase (cGMP PDE) isozymes...
January 20, 2023: Cancers
https://read.qxmd.com/read/36741517/the-anti-breast-cancer-stem-cell-properties-of-gold-i-non-steroidal-anti-inflammatory-drug-complexes
#30
JOURNAL ARTICLE
Alice Johnson, Chibuzor Olelewe, Jong Hyun Kim, Joshua Northcote-Smith, R Tyler Mertens, Ginevra Passeri, Kuldip Singh, Samuel G Awuah, Kogularamanan Suntharalingam
The anti-breast cancer stem cell (CSC) properties of a series of gold(i) complexes comprising various non-steroidal anti-inflammatory drugs (NSAIDs) and triphenylphosphine 1-8 are reported. The most effective gold(i)-NSAID complex 1, containing indomethacin, exhibits greater potency for breast CSCs than bulk breast cancer cells (up to 80-fold). Furthermore, 1 reduces mammosphere viability to a better extent than a panel of clinically used breast cancer drugs and salinomycin, an established anti-breast CSC agent...
January 18, 2023: Chemical Science
https://read.qxmd.com/read/36671001/seleno-analogs-of-scaffolds-resembling-natural-products-a-novel-warhead-toward-dual-compounds
#31
JOURNAL ARTICLE
Nora Astrain-Redin, Irene Talavera, Esther Moreno, María J Ramírez, Nuria Martínez-Sáez, Ignacio Encío, Arun K Sharma, Carmen Sanmartín, Daniel Plano
Nowadays, oxidative cell damage is one of the common features of cancer and Alzheimer's disease (AD), and Se-containing molecules, such as ebselen, which has demonstrated strong antioxidant activity, have demonstrated well-established preventive effects against both diseases. In this study, a total of 39 Se-derivatives were synthesized, purified, and spectroscopically characterized by NMR. Antioxidant ability was tested using the DPPH assay, while antiproliferative activity was screened in breast, lung, prostate, and colorectal cancer cell lines...
January 6, 2023: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/36670330/selective-cox-2-inhibitor-etoricoxib-s-liposomal-formulation-attenuates-m2-polarization-of-tams-and-enhances-its-anti-metastatic-potential
#32
JOURNAL ARTICLE
Usmani Mohammed Akif, Javed Miyan, Rafquat Rana, Moinuddin, Narayan Kumar Goswami, Tanzeela, Smrati Bhadauria, Manish Kumar Chourasia
INTRODUCTION: COX-2 inhibition in pro-tumoral M2 polarization of Tumor-Associated Macrophages (TAMs) underscore the improved prognosis and response to cancer therapy. Thus, etoricoxib, a COX-2 inhibiting NSAID drug is highly effective against tumorigenesis, but its compromised solubility and associated hepatotoxicity, and cardiotoxicity limit its clinical translation. OBJECTIVE: In view of the consequences, the proposed study entails the development of a liposomal formulation for etoricoxib and evaluates its anticancer potential...
January 20, 2023: Pharmaceutical Research
https://read.qxmd.com/read/36646396/perioperative-escape-from-dormancy-of-spontaneous-micro-metastases-a-role-for-malignant-secretion-of-il-6-il-8-and-vegf-through-adrenergic-and-prostaglandin-signaling
#33
JOURNAL ARTICLE
Rita Haldar, Lee Shaashua Berger, Ella Rossenne, Arielle Radin, Anabel Eckerling, Elad Sandbank, Erica K Sloan, Steve W Cole, Shamgar Ben-Eliyahu
We recently showed that a minimally-invasive removal of MDA-MB-231HM primary tumors (PTs) and elimination of their secreted factors (including IL-6, IL-8, VEGF, EGF, PDGF-aa, MIF, SerpinE1, and M-CSF), caused regression of spontaneous micro-metastases into a non-growing dormant state. To explore the underlying mechanisms and potential clinical ramifications of this phenomenon, we herein used the MDA-MB-231HM human breast cancer cell-line, in-vitro, and in vivo following orthotopic implantation in immune-deficient BALB/C nu/nu mice...
January 13, 2023: Brain, Behavior, and Immunity
https://read.qxmd.com/read/36639918/risk-factors-for-persistent-pain-after-breast-cancer-surgery-a-multicentre-prospective-cohort-study
#34
MULTICENTER STUDY
H S Tan, J K Plichta, A Kong, C W Tan, S Hwang, R Sultana, M C Wright, A T H Sia, B L Sng, A S Habib
Identifying factors associated with persistent pain after breast cancer surgery may facilitate risk stratification and individualised management. Single-population studies have limited generalisability as socio-economic and genetic factors contribute to persistent pain development. Therefore, this prospective multicentre cohort study aimed to develop a predictive model from a sample of Asian and American women. We enrolled women undergoing elective breast cancer surgery at KK Women's and Children's Hospital and Duke University Medical Center...
April 2023: Anaesthesia
https://read.qxmd.com/read/36596665/benign-breast-disease-nsaids-and-postmenopausal-breast-cancer-risk-in-the-cps-ii-cohort
#35
JOURNAL ARTICLE
Mark E Sherman, Robert A Vierkant, Matthew Masters, Derek C Radisky, Stacey J Winham, Amy C Degnim, Celine M Vachon, Alpa V Patel, Lauren R Teras
Non-steroidal anti-inflammatory agents (NSAIDs) are associated with modest inconsistent reductions in breast cancer (BC) risk in population-based cohorts, whereas two focused studies of benign breast disease (BBD) patients have found lower risk with NSAID use. Given that BBD includes fibroinflammatory lesions linked to elevated BC risk, we assessed whether NSAID use was associated with lower BC risk among BBD patients. Participants were postmenopausal women in the Cancer Prevention Study-II (CPS-II), a prospective study of cancer incidence and mortality, who completed follow-up surveys in 1997 with follow-up through June 30, 2015...
January 3, 2023: Cancer Prevention Research
https://read.qxmd.com/read/36494710/associations-of-aspirin-and-other-anti-inflammatory-medications-with-breast-cancer-risk-by-the-status-of-cox-2-expression
#36
JOURNAL ARTICLE
Lusine Yaghjyan, A Heather Eliassen, Graham Colditz, Bernard Rosner, Pepper Schedin, Akemi Wijayabahu, Rulla M Tamimi
BACKGROUND: We investigated the associations of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) with breast cancer risk by the status of COX-2 protein expression. METHODS: This study included 421 cases and 3,166 controls from a nested case-control study within the Nurses' Health Study (NHS) and Nurses' Health Study II (NHSII) cohorts. Information on medication use was first collected in 1980 (NHS) and 1989 (NHSII) and was updated biennially. Medication use was defined as none, past or current; average cumulative dose and frequency were calculated for all past or current users using data collected from all biannual questionnaires preceding the reference date...
December 9, 2022: Breast Cancer Research: BCR
https://read.qxmd.com/read/36467585/n-1-methyladenosine-modification-in-cancer-biology-current-status-and-future-perspectives
#37
REVIEW
Jiexin Li, Haisheng Zhang, Hongsheng Wang
Post-transcriptional modifications in RNAs regulate their biological behaviors and functions. N1 -methyladenosine (m1 A), which is dynamically regulated by writers, erasers and readers, has been found as a reversible modification in tRNA, mRNA, rRNA and long non-coding RNA (lncRNA). m1 A modification has impacts on the RNA processing, structure and functions of targets. Increasing studies reveal the critical roles of m1 A modification and its regulators in tumorigenesis. Due to the positive relevance between m1 A and cancer development, targeting m1 A modification and m1 A-related regulators has been of attention...
2022: Computational and Structural Biotechnology Journal
https://read.qxmd.com/read/36375380/systemic-nos2-depletion-and-cox-inhibition-limits-tnbc-disease-progression-and-alters-lymphoid-cell-spatial-orientation-and-density
#38
JOURNAL ARTICLE
Veena Somasundaram, Lisa A Ridnour, Robert Ys Cheng, Abigail J Walke, Noemi Kedei, Dibyangana D Bhattacharyya, Adelaide L Wink, Elijah F Edmondson, Donna Butcher, Andrew C Warner, Tiffany H Dorsey, David A Scheiblin, William Heinz, Richard J Bryant, Robert J Kinders, Stanley Lipkowitz, Stephen Tc Wong, Milind Pore, Stephen M Hewitt, Daniel W McVicar, Stephen K Anderson, Jenny Chang, Sharon A Glynn, Stefan Ambs, Stephen J Lockett, David A Wink
Antitumor immune polarization is a key predictor of clinical outcomes to cancer therapy. An emerging concept influencing clinical outcome involves the spatial location of CD8+ T cells, within the tumor. Our earlier work demonstrated immunosuppressive effects of NOS2 and COX2 tumor expression. Here, we show that NOS2/COX2 levels influence both the polarization and spatial location of lymphoid cells including CD8+ T cells. Importantly, elevated tumor NOS2/COX2 correlated with exclusion of CD8+ T cells from the tumor epithelium...
November 9, 2022: Redox Biology
https://read.qxmd.com/read/36309613/ketoprofen-suppresses-triple-negative-breast-cancer-cell-growth-by-inducing-apoptosis-and-inhibiting-autophagy
#39
JOURNAL ARTICLE
Indrajit Patra, Rana Hussein Naser, Fadhil Hussam, Noora M Hameed, Mustafa M Kadhim, Irshad Ahmad, Sura A Awadh, Doaa A Hamad, Rosario Mireya Romero Parra, Yasser Fakri Mustafa
BACKGROUND: Triple-negative breast cancer (TNBC) is an invasive phenotype with undesirable clinical features, poor prognosis, and therapy resistance. Ketoprofen is a Non-steroidal anti-inflammatory drug (NSAID) with anti-tumor properties. AIM: To investigate the effects of Ketoprofen on apoptosis and autophagy in TNBC cell line MDA-MB-231. METHODS: The cytotoxic activity of Ketoprofen was assayed by the MTS method. Flowcytometry was utilized to measure the number of apoptotic MDA-MB-231 cells...
October 29, 2022: Molecular Biology Reports
https://read.qxmd.com/read/36257283/design-synthesis-and-anticancer-evaluation-of-novel-se-nsaid-hybrid-molecules-identification-of-a-se-indomethacin-analog-as-a-potential-therapeutic-for-breast-cancer
#40
JOURNAL ARTICLE
Sandra Ramos-Inza, Ignacio Encío, Asif Raza, Arun K Sharma, Carmen Sanmartín, Daniel Plano
A total of twenty-five novel carboxylic acid, methylester, methylamide or cyano nonsteroidal anti-inflammatory drug (NSAID) derivatives incorporating Se in the chemical form of selenoester were reported. Twenty Se-NSAID analogs exhibited an increase in cytotoxic potency compared with parent NSAID scaffolds (aspirin, salicylic acid, naproxen, indomethacin and ketoprofen). Top five analogs were selected to further study their cytotoxicity in a larger panel of cancer cells and were also submitted to the DTP program of the NCI's panel of 60 cancer cell lines...
October 13, 2022: European Journal of Medicinal Chemistry
keyword
keyword
46585
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.